Standout Papers

Amyloid-Related Imaging Abnormalities in 2 Phase 3 Studies Evaluating Aducanumab in Patients With Early Alzheimer... 2021 2026 2022 2024383
  1. Amyloid-Related Imaging Abnormalities in 2 Phase 3 Studies Evaluating Aducanumab in Patients With Early Alzheimer Disease (2021)
    Stephen Salloway, Spyros Chalkias et al. JAMA Neurology

Immediate Impact

4 from Science/Nature 54 standout
Sub-graph 1 of 23

Citing Papers

Alzheimer’s Disease Detection Using Deep Learning on Neuroimaging: A Systematic Review
2024 Standout
Neuronal substance P drives metastasis through an extracellular RNA–TLR7 axis
2024 StandoutNature
2 intermediate papers

Works of Priya Singhal being referenced

Amyloid-Related Imaging Abnormalities in 2 Phase 3 Studies Evaluating Aducanumab in Patients With Early Alzheimer Disease
2021 Standout
Vascular endothelial growth factor-A165b prevents diabetic neuropathic pain and sensory neuronal degeneration
2015

Author Peers

Author Last Decade Papers Cites
Priya Singhal 138 304 23 122 14 520
Ying Tian 155 406 15 131 20 621
Kimberly Umans 106 288 23 103 12 552
Françoise Gerber 118 343 51 126 7 543
Malin Johannesson 130 319 4 154 16 547
Ülla Linnamägi 80 208 43 100 18 516
Kristen Morris 86 425 22 139 11 550
Andrew Marky 67 292 38 100 8 480
Brenda Yasie Lee 72 298 13 230 13 564
Shinji Sudoh 64 313 44 125 17 589
Gregory D. Van Vickle 94 500 16 160 6 600

All Works

Loading papers...

Rankless by CCL
2026